This report aims to provide insights into the global cell expansion market. It provides valuable information on the product, cell type, application, and end-users, in the cell expansion market.
The global cell expansion market is expected to reach USD 18.76 Billion by 2021 from USD 8.34 Billion in 2016 at a CAGR of 17.6%. The global cell expansion market is broadly classified into product, cell type, application, end-users, and regions.
Get Sample Copy Here@ www.reportsnreports.com/contacts/r…aspx?name=313419
The cell expansion market is expected to reach USD18.76 billion by 2021 from USD 8.34 billion in 2016 at a CAGR of 17.6%. The global cell expansion market is segmented based on product, cell type, application, end user, and region.The consumables segment is expected to register the highest growth rate in the cell expansion market, byproduct, during the forecast period. The high growth in this segment is attributed to the increasing investments in cell-based research.
Based on end user, the cell expansion market is segmented into research institutes, biopharmaceutical and biotechnology companies, cell banks, and others. The research institutes segment is expected to account for the largest share of the market in 2016.
The increasing prevalence of diseases and the need to develop new therapies will drive the growth of this market.
Geographically, the cell expansion market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American segment is primarily driven by rising government funding for research in the North American countries.
The major factors contributing to the growth of the cell expansion market include increasing government funding for research, high prevalence of chronic diseases, and growing number of GMP-certified production facilities. Furthermore, increasing R&D spending and new product development activities by companies is another major factor driving the growth of this market.
Access Cell Expansion Market 2017-2021 spreads across 189 pages profiling 10 companies and supported with 168 tables and 48 figures available at www.reportsnreports.com/contacts/d…aspx?name=313419
Target Audience for this Report:
- Cell expansion instrument manufacturers and suppliers
- Academic research institutes
- Biopharmaceutical and biotechnology companies
- Research and Development (R&D) companies
- Business research and consulting service providers
- Medical research laboratories
- Academic medical centers and universities
Fundamental from Table of Content
3 Executive Summary
3.2 Current Scenario
3.3 Future Outlook
12 Company Profiles
(Business Overview, Products, Company Snapshot, Recent Developments, MnM View)*
12.2 Thermo Fisher Scientific, Inc.
12.3 GE Healthcare (A Wholly Owned Subsidiary of General Electric Company)
12.4 Lonza Group Ltd.
12.5 Becton, Dickinson and Company
12.6 Corning, Inc.
12.7 Merck KGAA
12.8 Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
12.9 Miltenyi Biotec
12.10 Stemcell Technologies
12.11 Terumo BCT, Inc. (A Subsidiary of Terumo Corporation)
*Details on Company Financial Might Not Be Captured in Case of Unlisted Companies
Browse Here for full Report with TOC: www.reportsnreports.com/reports/31…ast-to-2019.html